Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jana Rolff

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Journal of Breath Research|February 11, 2015
In vitro cultured lung cancer cells are not suitable for animal-based breath biomarker detectionKristin Schallschmidt, Roland Becker, Hanna Zwaka, et al.
Plos One|August 6, 2015
A Natural Combination Extract of Viscum album L. Containing Both Triterpene Acids and Lectins Is Highly Effective against AML In VivoCatharina I Delebinski, Monika Twardziok, Susann Kleinsimon, et al.
Lung Cancer (Amsterdam, Netherlands)|September 22, 2014
Activation of AMP-activated protein kinase sensitizes lung cancer cells and H1299 xenografts to erlotinibHelen J Hülsmann, Jana Rolff, Christian Bender, et al.
JCI Insight|April 19, 2019
Prohibitin promotes de-differentiation and is a potential therapeutic target in neuroblastomaIan C MacArthur, Yi Bei, Heathcliff Dorado Garcia, et al.
Nucleic Acids Research|December 4, 2016
QSEA-modelling of genome-wide DNA methylation from sequencing enrichment experimentsMatthias Lienhard, Sabrina Grasse, Jana Rolff, et al.
Science Signaling|January 5, 2017
RETRACTED: The receptor tyrosine kinase AXL mediates nuclear translocation of the epidermal growth factor receptorToni M Brand, Mari Iida, Kelsey L Corrigan, et al.
Cancers|April 3, 2021
CD28 Co-Stimulus Achieves Superior CAR T Cell Effector Function against Solid Tumors Than 4-1BB Co-StimulusAna Textor, Laura Grunewald, Kathleen Anders, et al.
Translational Oncology|December 24, 2019
Small-Molecule Dual PLK1 and BRD4 Inhibitors are Active Against Preclinical Models of Pediatric Solid TumorsNatalie Timme, Youjia Han, Shuai Liu, et al.
Genome Medicine|July 22, 2018
Epigenomic profiling of non-small cell lung cancer xenografts uncover LRP12 DNA methylation as predictive biomarker for carboplatin resistanceSabrina Grasse, Matthias Lienhard, Steffen Frese, et al.
European Journal of Cancer (Oxford, England : 1990)|August 5, 2018
Influence of eukaryotic translation initiation factor 6 on non-small cell lung cancer development and progressionNadine Gantenbein, Eva Bernhart, Ines Anders, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Journal of Breath Research|February 11, 2015
In vitro cultured lung cancer cells are not suitable for animal-based breath biomarker detectionKristin Schallschmidt, Roland Becker, Hanna Zwaka, et al.
Plos One|August 6, 2015
A Natural Combination Extract of Viscum album L. Containing Both Triterpene Acids and Lectins Is Highly Effective against AML In VivoCatharina I Delebinski, Monika Twardziok, Susann Kleinsimon, et al.
Lung Cancer (Amsterdam, Netherlands)|September 22, 2014
Activation of AMP-activated protein kinase sensitizes lung cancer cells and H1299 xenografts to erlotinibHelen J Hülsmann, Jana Rolff, Christian Bender, et al.
JCI Insight|April 19, 2019
Prohibitin promotes de-differentiation and is a potential therapeutic target in neuroblastomaIan C MacArthur, Yi Bei, Heathcliff Dorado Garcia, et al.
Nucleic Acids Research|December 4, 2016
QSEA-modelling of genome-wide DNA methylation from sequencing enrichment experimentsMatthias Lienhard, Sabrina Grasse, Jana Rolff, et al.
Science Signaling|January 5, 2017
RETRACTED: The receptor tyrosine kinase AXL mediates nuclear translocation of the epidermal growth factor receptorToni M Brand, Mari Iida, Kelsey L Corrigan, et al.
Cancers|April 3, 2021
CD28 Co-Stimulus Achieves Superior CAR T Cell Effector Function against Solid Tumors Than 4-1BB Co-StimulusAna Textor, Laura Grunewald, Kathleen Anders, et al.
Translational Oncology|December 24, 2019
Small-Molecule Dual PLK1 and BRD4 Inhibitors are Active Against Preclinical Models of Pediatric Solid TumorsNatalie Timme, Youjia Han, Shuai Liu, et al.
Genome Medicine|July 22, 2018
Epigenomic profiling of non-small cell lung cancer xenografts uncover LRP12 DNA methylation as predictive biomarker for carboplatin resistanceSabrina Grasse, Matthias Lienhard, Steffen Frese, et al.
European Journal of Cancer (Oxford, England : 1990)|August 5, 2018
Influence of eukaryotic translation initiation factor 6 on non-small cell lung cancer development and progressionNadine Gantenbein, Eva Bernhart, Ines Anders, et al.
Pageof 3